☰

In-San Kim - Publications

Affiliations: 
1978-2014 Biochemistry & Cell Biology Kyungpook National University, Daegu, South Korea 
 1993-1993 Dermatology Jefferson Medical College, Philadelphia, PA, United States 
 1994-1996 Molecular Genetics University of Texas M. D. Anderson Cancer Center 
 2014- Biomedical Research Institute Korea Institute of Science and Technology, Daejeon, South Korea 
Website:
http://kist-ims.com/
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kim SA, Lee Y, Ko Y, Kim S, Kim GB, Lee NK, Ahn W, Kim N, Nam GH, Lee EJ, Kim IS. Protein-based nanocages for vaccine development. Journal of Controlled Release : Official Journal of the Controlled Release Society. 353: 767-791. PMID 36516900 DOI: 10.1016/j.jconrel.2022.12.022  0.401
2022 Kim SA, Kim S, Kim GB, Goo J, Kim N, Lee Y, Nam GH, Lim S, Kim T, Chang KH, Lee TG, Kim IS, Lee EJ. A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations. International Journal of Molecular Sciences. 23. PMID 35682801 DOI: 10.3390/ijms23116123  0.374
2021 Lee NK, Choi JU, Kim HR, Chung SW, Ko YG, Cho YS, Park SJ, Lee EJ, Kim SY, Kim IS, Byun Y. Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer. Biomaterials. 277: 121105. PMID 34478928 DOI: 10.1016/j.biomaterials.2021.121105  0.475
2021 Choi Y, Nam GH, Kim GB, Kim S, Kim YK, Kim SA, Kim HJ, Lee EJ, Kim IS. Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity. Cancer Gene Therapy. PMID 34349240 DOI: 10.1038/s41417-021-00372-y  0.463
2021 Kim GB, Sung HD, Nam GH, Kim W, Kim S, Kang D, Lee EJ, Kim IS. Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33794271 DOI: 10.1016/j.jconrel.2021.03.038  0.41
2021 Je H, Nam GH, Kim GB, Kim W, Kim SR, Kim IS, Lee EJ. Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33450317 DOI: 10.1016/j.jconrel.2021.01.016  0.43
2020 Kim GB, Nam GH, Hong Y, Woo J, Cho Y, Kwon IC, Yang Y, Kim IS. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Science Advances. 6. PMID 32937446 DOI: 10.1126/sciadv.aaz2083  0.305
2018 Kih M, Lee EJ, Lee NK, Kim YK, Lee KE, Jeong C, Yang Y, Kim DH, Kim IS. Designed trimer-mimetic TNF superfamily ligands on self-assembling nanocages. Biomaterials. 180: 67-77. PMID 30025246 DOI: 10.1016/J.Biomaterials.2018.07.009  0.418
2018 Nam GH, Lee EJ, Kim YK, Hong Y, Choi Y, Ryu MJ, Woo J, Cho Y, Ahn DJ, Yang Y, Kwon IC, Park SY, Kim IS. Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer. Nature Communications. 9: 2165. PMID 29867097 DOI: 10.1038/s41467-018-04607-9  0.42
2018 Lee EJ, Nam GH, Lee NK, Kih M, Koh E, Kim YK, Hong Y, Kim S, Park SY, Jeong C, Yang Y, Kim IS. Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer. Advanced Materials (Deerfield Beach, Fla.). PMID 29333661 DOI: 10.1002/adma.201705581  0.47
2017 Lee NK, Lee EJ, Kim S, Nam GH, Kih M, Hong Y, Jeong C, Yang Y, Byun Y, Kim IS. Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28821462 DOI: 10.1016/j.jconrel.2017.08.014  0.444
2017 Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, Kim IS. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 121: 121-129. PMID 28086180 DOI: 10.1016/j.biomaterials.2017.01.004  0.466
2016 Lee EJ, Lee NK, Kim IS. Bioengineered protein-based nanocage for drug delivery. Advanced Drug Delivery Reviews. PMID 26994591 DOI: 10.1016/j.addr.2016.03.002  0.376
2013 Choi KM, Kim K, Kwon IC, Kim IS, Ahn HJ. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo. Molecular Pharmaceutics. 10: 18-25. PMID 22663765 DOI: 10.1021/mp300211a  0.316
1996 Sinha S, Kim IS, Sohn KY, de Crombrugghe B, Maity SN. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Molecular and Cellular Biology. 16: 328-37. PMID 8524312 DOI: 10.1128/Mcb.16.1.328  0.539
Show low-probability matches.